Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
31
1
2
3
4
5
6
8
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
31
1
2
3
Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO [...]
Allergan to Present at the 37th Annual J.P. Morgan Healthcare Conference
2019-01-07    
3:30 pm
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, [...]
Johnson & Johnson to Participate in 37th Annual JP Morgan Health Care Conference
2019-01-07    
3:30 pm
Johnson & Johnson (NYSE: JNJ) will participate in the 37th Annual JP Morgan Health Care Conference on Monday, Jan. 7th, at the Westin St. Francis in San Francisco.  Joseph J. [...]
Halozyme Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference
2019-01-09    
10:30 am
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference in San [...]
International Conference on Chemistry, Chemical Engineering and Chemical Process
2019-01-30 - 2019-01-31    
All Day
It is a great pleasure and an honor to extend to you a warm invitation to attend the "International Conference on Chemistry, Chemical Engineering and [...]
Streamline HCP Workflow • Drive Patient Education • Navigate the Specialty Prescribing Landscape
2019-02-01    
12:00 am
The original and most comprehensive conference series dedicated entirely to strategies for effective utilization of e-Rx and EHR technologies is back for 2019. Whether new [...]
Latest News

WEX to Boost Healthcare Payments

Modernizing Medicine Showcases Dermatology-specific Suite

WEX Inc.

signed a definitive agreement to acquire one of the leading integrated software-as-a-service (SaaS) technologies and services provider, Benaissance. The transaction is valued at $80 million and is expected to close in the fourth quarter of 2015, subject to regulatory approvals.

The deal complements WEX’s efforts to enhance healthcare services by providing an expanded and differentiated payments solution. As a result, the company expects the acquisition to help it occupy a greater market share and boost customer loyalty and wallet share going ahead. Financially, the deal is expected to be accretive to the 2016 results of WEX, excluding one-time integration costs.

Benaissance, through its SaaS solutions has revolutionized premium billing and payment acceptance practices. The entity has already built a successful relationship with WEX’s Evolution1 platform over the past decade. On culmination of the deal, Benaissance will be integrated with the same.

The acquisition is expected to boost WEX’s offerings in the healthcare payment services space, which is indeed a high-growth area. In turn, this should boost the top line and be accretive to earnings.

WEX also remains focused on transforming its business into a multi-channel corporate payment solutions provider. Last month, the company purchased the remaining 49% interest in UNIK S.A. This is in addition to the 51% stake in UNIK that the insurer had acquired earlier in 2012. With this, WEX now has a 100% ownership in the entity.